Karen Lewis, Chief People Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 1,738 shares at $65.00 ($113K) on 2024-01-22, disclosed to the SEC on 2024-01-23.
Open-market sale of $113k APLS by Chief People Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| APLS | SELL | 2025-01-21 | $37K | — | Filing → |
| APLS | SELL | 2025-01-14 | $46K | — | Filing → |
| APLS | SELL | 2024-01-31 | $139K | — | Filing → |